Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC).
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC).
A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC). J Clin Oncol. 2005 Jun; 23(16_suppl):4669.
View in:
PubMed
authors with profiles
Walter M. Stadler